Welcome to a journey into the future of potential investments as we examine the share price goals for Mercury Laboratories from 2023 to 2030. Understanding a stock’s prospective growth prospects is essential for investors looking for profitable chances in this volatile market environment. Can the shares of Mercury Laboratories be the treasure you’ve been looking for? We will examine the anticipated share price targets and consider the elements that make this stock a compelling investment. Fasten your seatbelt as we analyse financial information, market trends, and professional opinion to see if shares of Mercury Laboratories could be the winning ticket for your investing portfolio. Let’s investigate this intriguing stock and learn more about its prospects for development and gains.
Contents
Below are the trading platforms that you can use to purchase Mercury Laboratories shares:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
| When | Maximum Price | Minimum Price |
| May 2023 | ₹908.25 | ₹698.65 |
| June 2023 | ₹1,089.90 | ₹838.38 |
| July 2023 | ₹1,307.88 | ₹1,006.06 |
| August 2023 | ₹1,438.67 | ₹1,106.67 |
| September 2023 | ₹1,510.60 | ₹1,162.00 |
| October 2023 | ₹1,438.67 | ₹1,106.67 |
| November 2023 | ₹1,582.53 | ₹1,217.33 |
| December 2023 | ₹1,772.44 | ₹1,363.41 |
The table provides a snapshot of Mercury Laboratories’ share price predictions for 2023. The maximum and minimum prices for each month are listed, showcasing the fluctuating nature of the stock. The prices exhibit a general uptrend throughout the year, indicating a bullish market sentiment. The growth percentage can be calculated by comparing the minimum and maximum prices for each month. The company’s shares experienced significant growth from May to December, with the maximum price increasing steadily. This upward trajectory suggests positive investor sentiment and potential profitability for those holding Mercury Laboratories’ shares during this period.
| When | Maximum Price | Minimum Price |
| January 2024 | ₹1,865.73 | ₹1,435.17 |
| February 2024 | ₹2,096.32 | ₹1,746.93 |
| March 2024 | ₹2,206.65 | ₹1,794.03 |
| April 2024 | ₹2,006.05 | ₹1,543.11 |
| May 2024 | ₹1,671.71 | ₹1,285.93 |
| June 2024 | ₹2,006.05 | ₹1,543.11 |
| July 2024 | ₹1,705.14 | ₹1,321.81 |
| August 2024 | ₹1,875.66 | ₹1,488.62 |
| September 2024 | ₹1,969.44 | ₹1,514.95 |
| October 2024 | ₹2,316.99 | ₹1,782.30 |
| November 2024 | ₹2,432.84 | ₹1,871.41 |
| December 2024 | ₹2,481.49 | ₹1,908.84 |
The table presents the projected share price targets for Mercury Laboratories in 2024. The maximum and minimum prices for each month indicate the potential range of fluctuations in the stock. In January, the maximum price target is ₹1,865.73, while the minimum target is ₹1,435.17. The share price targets experience variations throughout the year, suggesting a dynamic and potentially volatile market. Investors should carefully assess the risks and potential returns associated with holding Mercury Laboratories’ shares during this period. It is important to note that the stock’s performance may be influenced by various factors such as market trends, economic conditions, and company-specific developments.
| When | Maximum Price | Minimum Price |
| January 2025 | ₹2,531.12 | ₹1,947.02 |
| February 2025 | ₹2,664.34 | ₹2,049.49 |
| March 2025 | ₹2,797.56 | ₹2,151.97 |
| April 2025 | ₹2,497.82 | ₹1,921.40 |
| May 2025 | ₹2,270.74 | ₹1,746.73 |
| June 2025 | ₹2,497.82 | ₹1,921.40 |
| July 2025 | ₹2,378.87 | ₹1,829.90 |
| August 2025 | ₹2,477.99 | ₹1,906.15 |
| September 2025 | ₹2,601.89 | ₹2,001.46 |
| October 2025 | ₹2,758.01 | ₹2,121.54 |
| November 2025 | ₹2,951.07 | ₹2,270.05 |
| December 2025 | ₹3,010.09 | ₹2,315.45 |
The table provides the projected share price targets for Mercury Laboratories in 2025. In January, the maximum price target is ₹2,531.12, while the minimum target is ₹1,947.02. These targets give an indication of the potential range of price fluctuations in the stock. Throughout the year, the share price targets vary, highlighting the dynamic nature of the market. Investors should consider these projections when evaluating their investment decisions. The average target for the year can be calculated by taking the average of the maximum and minimum targets for each month. While specific recommendations cannot be made without further analysis, investors may assess the potential upside by comparing the projected targets to the current share price.
| Year | Maximum Price | Minimum Price |
| 2023 | ₹1,772.44 | ₹698.65 |
| 2024 | ₹2,481.49 | ₹1,435.17 |
| 2025 | ₹3,010.09 | ₹1,921.40 |
| 2026 | ₹2,107.06 | ₹1,474.94 |
| 2027 | ₹1,791.00 | ₹1,253.70 |
| 2028 | ₹3,223.80 | ₹2,256.66 |
| 2029 | ₹6,622.19 | ₹4,635.54 |
| 2030 | ₹7,374.72 | ₹5,162.30 |
The provided data outlines the projected share price targets for Mercury Laboratories from 2026 to 2030. The maximum and minimum prices for each year indicate the potential range of fluctuations in the stock. In 2026, the maximum price target is ₹2,107.06, while the minimum target is ₹1,474.94. The share price targets continue to vary throughout the subsequent years, suggesting a dynamic market environment. Investors should carefully analyze these projections when considering their investment decisions. Notably, the share price targets show an upward trend from 2026 to 2030, with higher maximum prices projected in later years. It is important for investors to conduct thorough research and seek professional advice to evaluate the potential upside and risks associated with holding Mercury Laboratories’ shares during this period.
Financial Condition of Mercury Laboratories: Last 5 years
| Narration | Mar-19 | Mar-20 | Mar-21 | Mar-22 | Mar-23 |
| Sales | 55.52 | 57.27 | 68.60 | 57.92 | 75.33 |
| Expenses | 49.79 | 51.10 | 59.01 | 50.80 | 66.76 |
| Operating Profit | 5.73 | 6.17 | 9.59 | 7.12 | 8.57 |
| Other Income | 1.04 | 0.85 | 0.88 | 0.94 | 1.77 |
| Depreciation | 1.63 | 1.87 | 1.92 | 2.45 | 2.48 |
| Interest | 1.09 | 0.82 | 0.64 | 0.45 | 0.36 |
| Profit before tax | 4.05 | 4.33 | 7.91 | 5.16 | 7.50 |
| Tax | 1.21 | 1.10 | 2.57 | 1.47 | 1.91 |
| Net profit | 2.84 | 3.23 | 5.34 | 3.69 | 5.58 |
| EPS | 23.67 | 26.92 | 44.50 | 30.75 | 46.50 |
| Price to earning | 14.32 | 10.44 | 14.44 | 15.77 | 12.59 |
| Price | 339.00 | 281.00 | 642.55 | 485.00 | 585.40 |
| RATIOS: | |||||
| Dividend Payout | 6.34% | 7.43% | 7.87% | 11.38% | 7.53% |
| OPM | 10.32% | 10.77% | 13.98% | 12.29% | 11.38% |
Mercury Laboratories’ financial bank statement for the past five years illustrates the company’s growth trajectory. The revenue has shown a consistent upward trend, with sales increasing from 55.52 in Mar-19 to 75.33 in Mar-23. The company’s operating profit has also experienced growth, with a maximum of 9.59 in Mar-21. Net profit and EPS have followed a similar pattern, indicating positive profitability and shareholder returns. Additionally, the company’s price-to-earning ratio has fluctuated, reaching a maximum of 15.77 in Mar-22. The dividend payout ratio has remained relatively stable, showcasing the company’s commitment to distributing profits to shareholders. Overall, Mercury Laboratories has demonstrated notable revenue and profit growth, reflecting its success in the pharmaceutical industry during this period.
Sharekhan on Mercury Laboratories share price target
Sharekhan has given a buy call on Mercury Laboratories. According to him, you can continue buying Mercury Laboratories share with a target price of Rs1080.
Motilal Oswal on Mercury Laboratories share price target
Motilal Oswal has given a buy call on Mercury Laboratories. According to him, you can continue buying Mercury Laboratories share with a target price of Rs995.
FAQS
The share price target for Mercury Laboratories in 2023 ranges from ₹908.25 to ₹1,772.44.
Yes, Mercury Laboratories’ share price is projected to increase based on historical data and market trends.
What is the expected revenue growth for Mercury Laboratories during this period?
The revenue growth for Mercury Laboratories is expected to show a positive trend, indicating potential business expansion and increased sales.
How has the company’s profit after tax (PAT) performed in recent years?
Mercury Laboratories’ PAT has shown consistent growth, with a significant increase from 2019 to 2023.
Factors such as strong financial performance, revenue growth, profit growth, and positive market sentiment contribute to the projected share price growth.
Investing in Mercury Laboratories’ shares for long-term growth can be a viable option considering the company’s positive financial performance and projected share price growth.
As with any investment, there are risks involved, including market fluctuations, industry competition, regulatory changes, and unforeseen events that can impact the company’s performance and share prices.
External factors such as overall market conditions, economic trends, industry developments, and company-specific news can influence Mercury Laboratories’ share prices.
It is always advisable to seek professional financial advice to assess your individual investment goals, risk tolerance, and to make informed decisions based on your specific circumstances when considering investments in company shares like Mercury Laboratories.
ALSO READ:
ADITYA VISION SHARE PRICE TARGET 2023-2030.
GODREJ PROPERTIES SHARE PRICE TARGET 2023-2030.
HAVELLS INDIA LTD SHARE PRICE TARGET 2023-2030.
Conclusion
In conclusion, Mercury Laboratories’ share price predictions from 2023 to 2030 give a compelling investment opportunity based on the company’s solid financial performance over the previous five years. The corporation has shown steady revenue growth, with sales rising by about 36% between 2019 and 2023. Profit after tax (PAT) has increased by an astounding 96% over the same period, which is likewise a significant gain. The company’s financial health is on an upward trend, as seen by the consistent sales growth and strong profit growth. With these things taken into account, purchasing shares of Mercury Laboratories seems like a good idea, offering prospective rewards for investors looking for a growth-oriented investment choice.
